close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about pharmaceuticals

Recent news which mentions pharmaceuticals

< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Stakes are high as Biogen faces investors next week at JPMorgan conference
Tags Insurance Pharmaceuticals Health Care
From Business Journals
Cincinnati startup files for IPO, quietly moves headquarters
Tickers INNO
Tags Health Care Pete Blackshaw Inno
From Business Journals
Stakes are high as Biogen faces investors next week at JP Morgan conference
Tags Health Care Biotech Insurance
From Business Journals
We're all in danger of new Covid variants until the world is vaccinated, experts warn
Tags Health care industry Coronavirus Social issues
From CNBC.com News
This map shows which countries are on track to meet the WHO’s Covid vaccination target
Tags Vaccinations Biotechnology Biotech and Pharmaceuticals
From CNBC.com News
NRx Pharmaceuticals takes second shot a getting emergency use approval for Covid-19 treatment
Tags Coronavirus David Schoenfeld Biotech
From Business Journals
Why Biogen's Alzheimer's drug Aduhelm is so controversial
Tags Health Insurance US: News Medicare
From CNBC.com News
Third former GSK scientist pleads guilty to stealing trade secrets for Chinese firm
Tags Jennifer Arbittier Williams Lucy Xi Yu Xue
From Business Journals
5 Short Squeeze Candidates To Watch: Insignia Systems Tops List With High Cost To Borrow, SeaChange Joins
Tickers AVCT ENSC ISIG PTPI
Tags Triller Short Sellers Fintel short squeeze
From Benzinga
Omicron is 'not the same disease' as previous Covid strains, Oxford University scientist says
Tags Coronavirus Europe Markets Health care industry
From CNBC.com News
Year in Review: Bay Area fed its drug habit with FDA approvals
Tags BioMarin Pharmaceutical Inc/ Health Care ChemoCentryx Inc/
From Business Journals
5 Beaten Down Biotech Stocks That Could Bounce Big In 2022
Tickers ACAD ALBO BIIB RCKT
Tags ALBO General News
From Benzinga
UK PM Boris Johnson to assess latest omicron data before deciding on new Covid curbs
Tags Coronavirus Europe Markets Health care industry
From CNBC.com News
Lab Notes: Lannett files FDA application for new drug; Virpax to start clinical trial for knee pain drug candidate
Tickers INNO
Tags Virpax Pharmaceuticals Inc/ Inno Tim Crew
From Business Journals
Drug company buys land for up to $250 million, 250-job Verona campus
Tickers INNO
Tags Technology Inno Pharmaceuticals
From Business Journals
How Much Revenue Could Pfizer's Oral COVID-19 Pill Fetch?
Tickers MRK PFE
Tags Coronavirus Covid/19 BofA Securities
From Benzinga
'Unmovable monster': The drug trial that changed how biotechs approach rare disease treatments
Tags Sarepta Therapeutics Inc/ (DE) Health Care Novartis AG
From Business Journals
Moderna Is Dipping: What's Next?
Tickers MRNA
Tags Short Ideas Health Care Benzinga
From Benzinga
French pharmaceutical giant Sanofi plans to pay up to $1.2B to buy a Peninsula cancer drug developer
Tags Genentech Inc/ Insurance Volker Schellenberger
From Business Journals
Verily shuffles leadership, shifting CEO Andy Conrad to long-range strategy
Tags Medical Devices Pharmaceuticals Insurance
From Business Journals
Executive Q&A: UTSA President Eighmy on Carnegie win and what it means
Tags Education Insurance Colleges & Universities
From Business Journals
New Moderna tests suggest its booster works to prevent omicron
Tags Pharmaceuticals Insurance Biotech
From Business Journals
Temple University gene editing spinoff forms partnership with Japanese distributor
Tags Pharmaceuticals Matthew Handel Insurance
From Business Journals
Malvern artificial intelligence-powered drug discovery firm raises $3.3M
Tickers INNO
Tags Pharmaceuticals Insurance Biotech
From Business Journals
New Moderna tests suggest its booster works to prevent omicron
Tags Moderna Inc/ Health Care Biotech
From Business Journals
< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today